Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases. [electronic resource]
Producer: 20161031Description: 670-5 p. digitalISSN:- 1879-114X
- Adult
- Antibodies, Monoclonal, Humanized -- adverse effects
- Female
- Humans
- Immune Reconstitution Inflammatory Syndrome -- chemically induced
- Leukoencephalopathy, Progressive Multifocal -- chemically induced
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Multiple Sclerosis -- drug therapy
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Natalizumab -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.